Since Fabp4–/– mice are also protected against obesity-associated hyperinsulinemia, the decrease in lipolysis-driven insulin secretion has been considered as one potential contributing factor to their reduced hyperinsulinemia and improved metabolic health (3, 5, 23). The gene discussed is FABP4; the disease is obesity disorder.